# Terros Inc

Health Center, AZ
Page: https://astrelis.co/providers/health_center/031000  
This twin: https://astrelis.co/providers/health_center/031000.md  
CMS Certification Number (CCN): 031000  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2020 to 2020)

Filings that are not a full fiscal year: FY2020 covers 182 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 30,527. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2020):** +1.5%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 15. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 9.8%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2020):** $3.5M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2020):** +18.0%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Terros Inc, AZ

Match to this profile: matched by name (method: name and state).

- FY ending 2025-09-30 (audit year 2025): balance sheet foots only; audit as filed https://app.fac.gov/dissemination/summary/2025-09-GSAFAC-0000405117
- FY ending 2024-09-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-09-GSAFAC-0000372629
- FY ending 2023-09-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-09-GSAFAC-0000030025

| Line | FY ending 2025-09-30 | FY ending 2024-09-30 | FY ending 2023-09-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 19,071,345 [derived, p.6] | 20,724,993 [derived, p.6] | 24,888,762 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 11,606,031 [derived, p.6] | 4,700,000 [derived, p.6] | 3,940,641 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 2,271,431 [derived, p.6] | 5,214,430 [derived, p.6] | 4,034,338 [derived, p.6] |
| other current assets (Statement of financial position) | 1,285,051 [derived, p.6] | 1,449,664 [derived, p.6] | 2,427,327 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 34,233,858 [extracted, p.6] | 32,089,087 [extracted, p.6] | 35,291,068 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 62,582,243 [derived, p.6] | 20,870,442 [derived, p.6] | 16,700,471 [derived, p.6] |
| other long-term assets (Statement of financial position) | 14,488,380 [derived, p.6] | 11,611,546 [derived, p.6] | 9,996,887 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 111,304,481 [extracted, p.6] | 64,571,075 [extracted, p.6] | 61,988,426 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 22,018,641 [derived, p.6] | 11,960,244 [derived, p.6] | 12,417,325 [derived, p.6] |
| deferred revenue (Statement of financial position) | 349,270 [derived, p.6] | 2,936,324 [derived, p.6] | 1,691,598 [derived, p.6] |
| current debt and leases (Statement of financial position) | 4,240,928 [derived, p.6] | 3,366,400 [derived, p.6] | 2,859,373 [derived, p.6] |
| other current liabilities (Statement of financial position) | 132,786 [derived, p.6] | 58,622 [derived, p.6] | 45,179 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 26,741,625 [extracted, p.6] | 18,321,590 [extracted, p.6] | 17,013,475 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 21,327,144 [derived, p.6] | 15,217,564 [derived, p.6] | 14,788,358 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 1,433,733 [derived, p.6] | 1,190,760 [derived, p.6] | 807,611 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 49,502,502 [extracted, p.6] | 34,729,914 [extracted, p.6] | 32,609,444 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 61,689,393 [derived, p.6] | 29,841,161 [derived, p.6] | 29,378,982 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 112,586 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 61,801,979 [extracted, p.6] | 29,841,161 [extracted, p.6] | 29,378,982 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 38,937,088 [derived, p.7] | 40,595,080 [derived, p.7] | 36,851,972 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 84,358,175 [derived, p.7] | 56,484,436 [derived, p.7] | 53,268,637 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 4,266,489 [derived, p.7] | 1,229,478 [derived, p.7] | 5,496,940 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 127,561,752 [extracted, p.7] | 98,308,994 [extracted, p.7] | 95,617,549 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 86,583,556 [derived, p.7] | 59,652,980 [derived, p.7] | 56,152,132 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | 2,751,221 [derived, p.7] | 2,631,646 [derived, p.7] | 2,610,430 [derived, p.7] |
| occupancy (Statement of activities) | 14,411,744 [derived, p.7] | 9,300,670 [derived, p.7] | 8,310,483 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 4,731,462 [derived, p.7] | 2,297,030 [derived, p.7] | 2,003,502 [derived, p.7] |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 40,447,487 [derived, p.7] | 24,191,222 [derived, p.7] | 23,041,166 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 148,925,470 [extracted, p.7] | 98,073,548 [extracted, p.7] | 92,117,713 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| non-operating and other changes (Statement of activities) | 2,097,689 [derived, p.7] | 226,733 [derived, p.7] | 202,363 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | -19,266,029 [extracted, p.7] | 462,179 [extracted, p.7] | 3,702,199 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 29,841,161 [extracted, p.7] | 29,378,982 [extracted, p.7] | 25,676,783 [extracted, p.7] |
| net assets, end (Statement of activities) | 61,801,979 [extracted, p.7] | 29,841,161 [extracted, p.7] | 29,378,982 [extracted, p.7] |

| Ratio | FY ending 2025-09-30 | FY ending 2024-09-30 | FY ending 2023-09-30 |
|---|---:|---:|---:|
| Days cash on hand | 48 days [plausible] | 79 days [plausible] | 101 days [plausible] |
| Current ratio | 1.28x [plausible] | 1.75x [plausible] | 2.07x [plausible] |
| Operating margin | absent [not computed] | absent [not computed] | absent [not computed] |
| Total margin | -15.1% [plausible] | 0.5% [plausible] | 3.9% [plausible] |
| Patient revenue share | 30.5% [plausible] | 41.3% [plausible] | 38.5% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 58.1% [plausible] | 60.8% [plausible] | 61.0% [plausible] |
| Days in patient receivables | 109 days [plausible] | 42 days [plausible] | 39 days [plausible] |
| Debt to net assets | 0.41x [plausible] | 0.62x [plausible] | 0.60x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Terros Inc; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Terros Inc", https://astrelis.co/providers/health_center/031000, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.